Where is Keeler located?

Keeler is headquartered in Windsor, United Kingdom.

How many employees does Keeler have?

As of Jun 30, 2026, the latest employee count at Keeler is 231.

Where does Keeler rank among its competitors?

Keeler ranks 6th amongst 75 active competitors, of which 10 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was IRIDEX, which secured $10M in Mar, 2025.

Who are the top competitors of Keeler?

Keeler's top competitors include Perfuse Therapeutics, IRIDEX and MicroSurgical Technology. Among them, IRIDEX secured the most recent funding round in March, 2025.

Keeler - 2026 Company Profile & Competitors

Keeler is an unfunded company based in Windsor (United Kingdom), founded in 1917. It operates as an A portfolio of ophthalmic devices. Keeler has not raised any funding yet. The company has 75 active competitors, including 10 funded and 18 that have exited. Its top competitors include companies like Perfuse Therapeutics, IRIDEX and MicroSurgical Technology.

Company Details

Keeler develops a portfolio of ophthalmic devices. Products developed by the company include Direct Ophthalmoscopes, Retinoscopes, Indirect Ophthalmoscopes, Dental Loupes, Loupe Light Systems, Surgical Loupes, Tonometers, Diagnostic Sets, Cryosurgical Instruments, Ophthalmoscopes, Retinal Probe, portable Slit Lamp, Otoscopes, and Accessories.

Website: www.keeler.co.uk/
Social
Email ID: *****@keeler.co.uk
Phone Number: +44 **********, +44 **********

Key Metrics

Founded Year

1917

Location

Windsor, United Kingdom

Stage

Unfunded

Ranked

6^th among 75 active competitors

Employee Count

231 as on Jun 30, 2026

Similar Companies

Perfuse Therapeutics & 85 more

View Keeler's full profile

Keeler has not raised any funding rounds yet.

Keeler's employee count trend

Keeler has 231 employees as of Jun 26. Here is Keeler's employee count trend over the years:

Uncover Keeler's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Keeler include Perfuse Therapeutics, IRIDEX and MicroSurgical Technology. Here is the list of Top 10 competitors of Keeler, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Perfuse Therapeutics 2018, San Francisco (United States), Acquired	Developer of therapies to treat eye disorders	-	Access Industries, Lilly Asia Ventures & 3 others	49/100
2nd	IRIDEX 1989, Mountain View (United States), Public	Manufacturer of ophthalmic laser systems and surgical instruments for eyes	-	Incubic, Technology Partners & 1 others	47/100
3rd	MicroSurgical Technology 1976, Redmond (United States), Acquired	Develops a portfolio of Surgical tools for Ophthalmic surgeries	-	-	47/100
4th	Dopavision 2017, Berlin (Germany), Series A	Developer of a digital therapeutic for myopia	$17.4M	Boehringer Ingelheim Venture Fund, Seventure Partners ... & 9 others	45/100
5th	Oertli Instrumente 1955, Berneck (Switzerland), Unfunded	Developer of ophthalmology medical device	-	-	44/100
6th	Keeler 1917, Windsor (United Kingdom), Unfunded	A portfolio of ophthalmic devices	-	-	44/100
7th	Lalji International 2018, Ahmedabad (India), Unfunded	Manufacturer of disposable medical drapes and surgical gowns. The company produces a variety of products for various medical applications, including ophthalmology, gynecology, and general surgery. These products are designed for single-use and contribute to maintaining a sterile environment during procedures. The manufacturing process emphasizes quality control to ensure the safety and efficacy of the products. The company's offerings also include hospital beds and related furniture.	-	-	42/100
8th	Lamellar 2007, Glasgow (United Kingdom), Series C	Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies	$18.4M	Hambro Perks, Invesco & 4 others	42/100
9th	Ziemer Ophthalmology 2005, Basel (Switzerland), Series B	Portfolio of devices for refractive and corneal surgery	$17.4M	BV Partners, HBM Partners & 1 others	40/100
10th	Katena 1975, Tampa (United States), Acquired	Ophthalmic surgical products for sight restoration, clinician support, and patient care	$7.5M	Audax Private Equity	40/100